DrugTheGuide
Pharmacokinetics

Two-Compartment Model

A pharmacokinetic model describing drug behaviour as a biexponential process — rapid initial distribution to a peripheral compartment followed by slower terminal elimination, producing an alpha phase and a beta phase in the plasma concentration-time curve.

Definition

The two-compartment model extends the simpler one-compartment model by recognising that many drugs do not distribute instantaneously throughout the body. Instead, they rapidly equilibrate with blood and highly perfused tissues (the central compartment) and more slowly distribute to peripheral tissues such as muscle, fat, or poorly perfused organs (the peripheral compartment).

After an intravenous bolus dose, plasma concentration follows a biexponential decline:

C(t) = A·e−αt + B·e−βt

Where α (fast hybrid rate constant) represents the distribution phase and β (slow hybrid rate constant) represents the elimination phase. A and B are intercepts on the concentration axis. The terminal half-life t½β = 0.693/β is the clinically relevant half-life for dosing. Background: NCBI two-compartment model review ↗.

α phase (distribution) β phase (elimination) Time ln Cp

Log-linear plasma concentration vs time after IV bolus: biexponential decline

Central vs Peripheral Compartment

Central compartment (V1)

Blood plasma, heart, lungs, liver, kidneys — well-perfused tissues that equilibrate rapidly with blood. Drug concentrations here are measured directly in plasma/serum. V1 is smaller than total Vd.

Peripheral compartment (V2)

Muscle, adipose, bone, slowly perfused tissues. Drug distributes here more slowly. During the alpha phase, drug is entering this compartment; during beta, drug returns from it to be eliminated via the central compartment.

Total apparent volume of distribution at steady state: Vss = V1 + V2. See our volume of distribution glossary and apparent Vd glossary.

Clinical Relevance and TDM Implications

  • Vancomycin: Follows two-compartment kinetics. Trough samples drawn before the end of the alpha phase (e.g. <1h post-infusion) will be falsely elevated. The 2020 ASHP/IDSA/SIDP consensus recommends AUC-guided TDM (PubMed) ↗ using Bayesian software to account for two-compartment behaviour. See our AUC glossary and TDM guide.
  • Aminoglycosides: Gentamicin and tobramycin show two-compartment kinetics; the tissue accumulation in renal cortex (peripheral compartment) drives nephrotoxicity. Extended-interval dosing exploits the prolonged post-antibiotic effect while allowing trough concentrations to fall near zero, reducing accumulation-related toxicity.
  • Digoxin: Has a prominent distribution phase (~6–8h after oral dose). TDM samples must be drawn at least 6–8h post-dose to ensure the alpha phase is complete — earlier samples give falsely high concentrations not reflective of tissue concentrations. See DailyMed digoxin prescribing information ↗.
  • Chemotherapy: Methotrexate (two-compartment), cisplatin, carboplatin — AUC-based dosing with carboplatin uses the Calvert formula targeting a specific AUC. Two-compartment models are used in oncology PK software to optimise dosing.

Reference: PubMed: two-compartment clinical pharmacokinetics ↗. FDA guidance on compartmental analysis: FDA NCA and compartmental PK guidance ↗.

FAQ

What is the two-compartment pharmacokinetic model?
The two-compartment model describes drug distribution as occurring between two distinct compartments: the central compartment (blood and highly perfused organs that equilibrate rapidly) and a peripheral compartment (tissues that equilibrate more slowly). After IV administration, plasma concentration initially declines rapidly due to distribution (alpha phase), then more slowly due to elimination (beta phase), producing a biexponential curve.
What is the difference between the alpha and beta phases?
The alpha (α) phase is the initial rapid decline in plasma concentration after IV administration, driven primarily by drug distribution from the central to the peripheral compartment. The beta (β) phase is the slower terminal decline once distribution equilibrium is reached, representing true elimination. The half-life associated with the beta phase (t½β) is the true elimination half-life relevant to dosing interval and steady-state calculations.
Which drugs show two-compartment kinetics?
Drugs with significant tissue distribution tend to follow two-compartment kinetics: vancomycin, aminoglycosides (gentamicin, tobramycin), digoxin, lidocaine, and many chemotherapy agents including methotrexate and cisplatin. The distinction matters for TDM: trough samples drawn too early (during the alpha phase) will show falsely low concentrations that do not reflect tissue equilibrium.
When should TDM samples be drawn for two-compartment drugs?
For two-compartment drugs, TDM samples must be drawn after the distribution phase (alpha phase) has completed — i.e., once the drug has equilibrated between compartments. For vancomycin, this is typically 1–2 hours after the end of infusion for peak samples, or just before the next dose for trough samples. Drawing too early gives spuriously high concentrations (still in the alpha phase). The 2020 vancomycin consensus guidelines recommend AUC-guided monitoring over trough-only approaches.